Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus propofol for total intravenous general anesthesia in elective oral and maxillofacial surgery
ChiCTR2500101918Phase 4Not yet recruiting
- Sponsor
- Nanjing Stomatological Hospital
- Start
- May 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and propofol (2 arms), sponsored by Nanjing Stomatological Hospital. Primary endpoints: QoR-15 score 24 hours post-surgery and Incidence of hypotension during induction and maintenance period. Planned start May 2025; status: not yet recruiting.
02
Drugs
ciprofolpropofol
Beyond the preview
Go deeper on ChiCTR2500101918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101918.